Skip to contentN
NEUROONE MEDICAL TECHNOLOGIES Corp
N
NMTCNEUROONE MEDICAL TECHNOLOGIES Corp Q4 2025 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$2.74M$2.74Mderived+906.6% vs Q4 2024 Net Income-$1.62M-$1.62MderivedN/M vs Q4 2024 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
NEUROONE MEDICAL TECHNOLOGIES Corp · CIK 1500198 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$1,528,621+983.7% Operating Incomederived-$1,371,064N/M Operating Cash Flowderived-$1,525,672N/M Free Cash Flowderived-$1,536,279N/M Margins · derivedGross margin55.8%+4.0 pt vs Q4 2024
Operating margin-50.0%+984.5 pt vs Q4 2024
Net margin-59.1%+1171.5 pt vs Q4 2024
ended Sep 30, 2025 · filed Dec 17, 2025 · 78 d after period end